BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17337137)

  • 1. Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.
    Charlton ST; Davis SS; Illum L
    Int J Pharm; 2007 Jun; 338(1-2):94-103. PubMed ID: 17337137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
    Charlton ST; Davis SS; Illum L
    J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
    Charlton S; Jones NS; Davis SS; Illum L
    Eur J Pharm Sci; 2007 Mar; 30(3-4):295-302. PubMed ID: 17223022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous system.
    Charlton ST; Davis SS; Illum L
    J Drug Target; 2007 Jun; 15(5):370-7. PubMed ID: 17541846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo.
    Zhang YJ; Ma CH; Lu WL; Zhang X; Wang XL; Sun JN; Zhang Q
    Acta Pharmacol Sin; 2005 Nov; 26(11):1402-8. PubMed ID: 16225765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.
    Shahiwala A; Misra A
    J Pharm Pharmacol; 2006 Jan; 58(1):19-26. PubMed ID: 16393460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
    Zaki NM; Awad GA; Mortada ND; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):89-96. PubMed ID: 16942844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine uptake into rat brain following intra-olfactory transport.
    Barakat NS; Omar SA; Ahmed AA
    J Pharm Pharmacol; 2006 Jan; 58(1):63-72. PubMed ID: 16393465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
    Lu W; Jiang W; Chen J; Yin M; Wang Z; Jiang X
    Int J Pharm; 2008 Feb; 349(1-2):196-205. PubMed ID: 17904315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Site-specific drug delivery systems. III. Nasal drug delivery].
    Szente V; Zelkó R
    Acta Pharm Hung; 2008; 78(2):87-90. PubMed ID: 18807389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
    Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
    Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of bioadhesive in-situ nasal gel of ketorolac tromethamine.
    Chelladurai S; Mishra M; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1596-9. PubMed ID: 18981612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium.
    Mistry A; Glud SZ; Kjems J; Randel J; Howard KA; Stolnik S; Illum L
    J Drug Target; 2009 Aug; 17(7):543-52. PubMed ID: 19530905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
    Bshara H; Osman R; Mansour S; El-Shamy Ael-H
    Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.